Detalles de la búsqueda
1.
Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-944462
2.
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-427948
3.
Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variant
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-443299
4.
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-439482
5.
Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-428137
6.
Validation of a SARS-CoV-2 spike ELISA for use in contact investigations and serosurveillance
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-057323
7.
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-domain Camelid Antibodies
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-010165
8.
Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-444010
9.
mRNA-1273 efficacy in a severe COVID-19 model: attenuated activation of pulmonary immune cells after challenge
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-428136
10.
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-166033
11.
Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-096511
12.
Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman Primates
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-440647
13.
Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-433390
14.
Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-432969
15.
LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-318972
16.
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-145920
17.
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-465542
18.
Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman Primates
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-456015
19.
Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman Primates
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-445189
20.
LY-CoV1404 potently neutralizes SARS-CoV-2 variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-442182
Resultados
1 -
20
de 20
1
Próxima >
>>